<p>A. Survival in relation to median cortisol level of 475 nmol/L. p = 0.0014, Hazard Ratio 0.35, 95% CI 0.19–0.67. B. Survival in relation to median stimulated cortisol level of 742 nmol/L. p = 0.015, Hazard Ratio 0.4496, 95% CI 0.24–0.86. C. Survival in relation to median dehydroepiandrosterone level of 15.5 nmol/L. p = 0.0236, Hazard Ratio 2.09, 95% CI 1.104 to 3.955. D. Survival in relation to median dehydroepiandrosterone-sulfate level of 2.4 umol/L. p = 0.1490, Hazard Ratio 1.60, 95% CI 0.85–3.80. E. Survival in relation to median cortisol/DHEA level of 27 nmol/nmol. p = 0.0002, Hazard Ratio 0.32, 95% CI 0.17–0.61. F: Survival in relation to median cortisol/DHEAS level of 203 nmol/micromol. p = 0.0004, Hazard Ratio 0.31, 95% CI 0.17–0...
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
<p>(A). Overall median survival of 15.0 months; (B) Stratified median survival based on FIGO staging...
<p>The Kaplan-Meier curves of disease-specific survival in relation to combinations of (A) (pCDK1<su...
<p>Values are shown for A. Cortisol (p = 0.005); B. DHEA (p = 0.015); C. Cortisol/DHEAS (p = 0.08). ...
<p>Overall survival (OS) according to (A) thyroid-stimulating hormone (TSH) levels (TSH≤1.7 vs. >1.7...
A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...
<p>Kaplan-Meier survival curves stratified by (A) 1,25(OH)<sub>2</sub>D levels, (B) the ratio of 1,2...
<p>Kaplan-Meier survival curves for 30-day survival according to the cutoff (>2.6 mmol/L) in all pat...
<p>Kaplan-Meier survival curves of the effects of statins plus n-3 PUFA as compared with statins alo...
<p>The Kaplan-Meier curves of disease-specific survival in relation to combinations of (A) (pCDK1<su...
<p>A higher median survival time was observed for PTX group (2185 days) [superior dashed line] than ...
<p>Kaplan-Meier survival curve according to serum albumin level in the unmatched and matched cohorts...
<p>(A) The survival rate in men (Low group: 96.2% at 1 year and 78.7% at 5 years; High group: 85.5% ...
<p>Kaplan-Meier survival curves analyzed using the log-rank test and the Holm-Sidak test for multipl...
<p>Kaplan-Meier survival curves of the effects of statins plus n-3 PUFA as compared with statins alo...
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
<p>(A). Overall median survival of 15.0 months; (B) Stratified median survival based on FIGO staging...
<p>The Kaplan-Meier curves of disease-specific survival in relation to combinations of (A) (pCDK1<su...
<p>Values are shown for A. Cortisol (p = 0.005); B. DHEA (p = 0.015); C. Cortisol/DHEAS (p = 0.08). ...
<p>Overall survival (OS) according to (A) thyroid-stimulating hormone (TSH) levels (TSH≤1.7 vs. >1.7...
A: Kaplan-Meier survival curve for major adverse cardiovascular events (MACE: cardiovascular death, ...
<p>Kaplan-Meier survival curves stratified by (A) 1,25(OH)<sub>2</sub>D levels, (B) the ratio of 1,2...
<p>Kaplan-Meier survival curves for 30-day survival according to the cutoff (>2.6 mmol/L) in all pat...
<p>Kaplan-Meier survival curves of the effects of statins plus n-3 PUFA as compared with statins alo...
<p>The Kaplan-Meier curves of disease-specific survival in relation to combinations of (A) (pCDK1<su...
<p>A higher median survival time was observed for PTX group (2185 days) [superior dashed line] than ...
<p>Kaplan-Meier survival curve according to serum albumin level in the unmatched and matched cohorts...
<p>(A) The survival rate in men (Low group: 96.2% at 1 year and 78.7% at 5 years; High group: 85.5% ...
<p>Kaplan-Meier survival curves analyzed using the log-rank test and the Holm-Sidak test for multipl...
<p>Kaplan-Meier survival curves of the effects of statins plus n-3 PUFA as compared with statins alo...
(a) Progression-free survival and (b) overall survival for patients with more than 70% reduction in ...
<p>(A). Overall median survival of 15.0 months; (B) Stratified median survival based on FIGO staging...
<p>The Kaplan-Meier curves of disease-specific survival in relation to combinations of (A) (pCDK1<su...